UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.84 +0.82 (+1.05%) GOLD FUTURES
2,393.80 +33.90 (+1.44%) DOW
39,908.00 +349.89 (+0.88%) Bitcoin GBP
52,102.89 +3,541.87 (+7.29%)
Bio-Rad Laboratories, Inc. (BIO-B)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 8.31B |
| Enterprise value | 8.07B |
| Trailing P/E | N/A |
| Forward P/E | 25.71 |
| PEG ratio (5-yr expected) | 1.06 |
| Price/sales (ttm) | 3.11 |
| Price/book (mrq) | 0.88 |
| Enterprise value/revenue | 3.10 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.94 |
| 52-week change 3 | -25.14% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 387.55 |
| 52-week low 3 | 271.00 |
| 50-day moving average 3 | 313.11 |
| 200-day moving average 3 | 330.96 |
Share statistics
| Avg vol (3-month) 3 | 270 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 5.08M |
| Implied shares outstanding 6 | 28.99M |
| Float 8 | 19.96M |
| % held by insiders 1 | 97.88% |
| % held by institutions 1 | 0.08% |
| Shares short (30 Apr 2024) 4 | 76 |
| Short ratio (30 Apr 2024) 4 | 1.9 |
| Short % of float (30 Apr 2024) 4 | 0.05% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.00% |
| Shares short (prior month 28 Mar 2024) 4 | 11 |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 08 Mar 2002 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -12.37% |
| Operating margin (ttm) | 8.48% |
Management effectiveness
| Return on assets (ttm) | 1.69% |
| Return on equity (ttm) | -3.43% |
Income statement
| Revenue (ttm) | 2.61B |
| Revenue per share (ttm) | 90.02 |
| Quarterly revenue growth (yoy) | -9.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 502.99M |
| Net income avi to common (ttm) | -322.37M |
| Diluted EPS (ttm) | -10.69 |
| Quarterly earnings growth (yoy) | 456.70% |
Balance sheet
| Total cash (mrq) | 1.65B |
| Total cash per share (mrq) | 57.69 |
| Total debt (mrq) | 1.4B |
| Total debt/equity (mrq) | 15.47% |
| Current ratio (mrq) | 6.57 |
| Book value per share (mrq) | 317.32 |
Cash flow statement
| Operating cash flow (ttm) | 346.57M |
| Levered free cash flow (ttm) | 120.82M |
© 2024 Yahoo. All rights reserved.